Semaglutide | U Store

Buy Semaglutide Online — GLP-1 Weight Loss from Ultima Pharmaceuticals

Also known as: Ozempic · Wegovy · Rybelsus · GLP-1 agonist · Semaglutide injection

Semaglutide is a GLP-1 receptor agonist originally developed for type 2 diabetes management and now one of the most clinically validated compounds available for significant weight loss. By mimicking the glucagon-like peptide-1 hormone it reduces appetite, slows gastric emptying, and improves insulin sensitivity — producing substantial and sustained reductions in body weight in both diabetic and non-diabetic individuals. All Semaglutide products at U Store are sourced from verified manufacturers, independently lab-tested, and shipped discreetly worldwide.

We found 3 products available for you.

Top review rate
Ultima-Semaglutide Semaglutide  buy online
$90.00

Ultima-Semaglutide

1 vial x 5 mg
Clients Review:
UltimaSS

$90 for 5mg vial from Ultima is the best value sema on the site. Quality checks out, been using it 3 months, down 31lbs total. Nothing else to say really

SEMAGLUTIDE - A-TECH LABS Semaglutide  buy online
$186.00

SEMAGLUTIDE - A-TECH LABS

1 vial x 5 mg + 1 amp sterilized water
Clients Review:
SlowTit

reconstituted fine, no issues with the bacteriostatic water included. been running 0.5mg weekly to start and already noticing appetite is significantly reduced by day 2 post injection. lost 9lbs in first month without changing training. will titrate up to 1mg next month. packaging was discreet, product arrived well within expected timeframe.

Pharmaqo – Semaglutide (Multi-Dose Pen) Semaglutide  buy online
Clients Review:
PenPreferred

Pharmaqo – Semaglutide (Multi-Dose Pen) The pen format is a genuinely better experience than vials and syringes. Dial in your dose, inject, done. No reconstitution, no measuring, nothing to mess up. Been on 1mg weekly for 6 weeks now, down 14lbs, eating maybe 1800 calories a day without any real effort or hunger. The appetite suppression kicks in hard around day 3 after each injection and stays through most of the week. At $172 for a 5mg pen this is the most convenient option on the site for sema.

About Semaglutide

Semaglutide is a synthetic analogue of human GLP-1 (glucagon-like peptide-1), a naturally occurring incretin hormone secreted by the gut in response to food intake. It shares approximately 94% structural homology with native GLP-1 but has been modified to resist enzymatic degradation, extending its half-life to approximately 7 days and allowing once-weekly subcutaneous administration.

Mechanism of action

Semaglutide activates GLP-1 receptors in the pancreas, brain, gastrointestinal tract, and cardiovascular system. In the pancreas it stimulates glucose-dependent insulin secretion and suppresses glucagon release, improving blood sugar regulation. In the brain — particularly the hypothalamus — it acts on appetite-regulating centers to reduce hunger signals and increase satiety. In the gastrointestinal tract it slows gastric emptying, prolonging the feeling of fullness after meals. Together these effects produce a significant and sustained reduction in caloric intake.

Weight loss applications

Clinical trials for Wegovy (high-dose Semaglutide at 2.4mg weekly) demonstrated average weight loss of 15 to 17% of total body weight over 68 weeks in non-diabetic obese individuals — outcomes previously only achievable through bariatric surgery. This established Semaglutide as a genuine pharmacological breakthrough in weight management. Results are dose-dependent, with higher doses producing greater weight loss but also more gastrointestinal side effects during titration.
Use in performance sports

In the bodybuilding and performance community Semaglutide is used during cutting phases and offseason recomposition to reduce body fat while preserving lean mass. Its appetite-suppressing effects allow users to maintain a caloric deficit with significantly less hunger and food cravings. It also improves insulin sensitivity, which is particularly relevant for users running high-calorie bulking phases or those using insulin-sensitizing compounds. The key consideration is managing caloric intake sufficiently to fuel training and preserve muscle mass while on Semaglutide.

Titration and side effects

Semaglutide is introduced at a low starting dose and titrated upward gradually — typically every 4 weeks — to minimize gastrointestinal side effects including nausea, vomiting, and diarrhea. These side effects are most pronounced during dose increases and generally subside as the body adapts. Starting too high or increasing too quickly is the most common cause of intolerance.

Frequently Asked Questions

Semaglutide is used for weight management and blood sugar control in type 2 diabetes. As Ozempic it is prescribed for diabetes management and cardiovascular risk reduction. As Wegovy it is approved specifically for chronic weight management in overweight and obese individuals. In performance and fitness contexts it is used during cutting phases for appetite suppression and body fat reduction.

Semaglutide for weight loss and diabetes is administered as a once-weekly subcutaneous injection, typically into the abdomen, thigh, or upper arm. An oral form (Rybelsus) exists for diabetes management but has lower and more variable bioavailability compared to the injectable format and is less commonly used for weight loss purposes.

Clinical trial data shows average weight loss of 15 to 17% of total body weight at the full 2.4mg weekly dose over approximately 68 weeks. Individual results vary significantly depending on diet, activity level, starting weight, and dose. Most users begin to see meaningful results within the first 4 to 8 weeks as the dose is titrated upward.

Semaglutide itself does not directly cause muscle loss, but the significant caloric deficit it produces can lead to loss of lean mass if protein intake and resistance training are not maintained. Users in performance settings typically combine Semaglutide with high protein intake, structured resistance training, and in some cases anabolic compounds to preserve muscle while losing fat.

The most common side effects are gastrointestinal — nausea, vomiting, diarrhea, constipation, and reduced appetite. These are most pronounced during dose escalation and typically improve over time. Serious but rare side effects include pancreatitis and gallbladder disease. Semaglutide is contraindicated in individuals with a personal or family history of medullary thyroid carcinoma.

Both are incretin-based weight loss compounds but Tirzepatide activates two receptors — GLP-1 and GIP — compared to Semaglutide's single GLP-1 target. Clinical data shows Tirzepatide produces greater average weight loss (up to 22% of body weight) compared to Semaglutide. However, Semaglutide has a longer track record, more extensive real-world data, and broader availability.

Decentralized Shipping

US Domestic and
International delivery

Decentralized Shipping

Orders Insurance

Free and easy reships
of lost parcels

Orders Insurance

Online Support

24 hours a day
7 days a week

Online Support

Flexible Payment

Pay with Credit Cards
Zelle and Crypto Coins

Flexible Payment

Shopping bag

There are currently no items in your cart.


Query must be at least 3 and at most 35 characters!